about
Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesisDeficiency of superoxide dismutase impairs protein C activation and enhances susceptibility to experimental thrombosisProteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic CancerVenous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis.Real-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow CytometryExisting data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort.[Prophylaxis and treatment of venous thromboembolism in cancer patients. Clinical value of low-molecular-weight heparins].Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH.Lumbar punctures in thrombocytopenic children with cancer.Venous thromboembolism in cancer patients.Venous Thromboembolism in Patients With Thrombocytopenia: Risk Factors, Treatment, and Outcome.Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study.Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study.Recurrent Deep Vein Thrombosis After the First Venous Thromboembolism Event: A Single-Institution Experience.Clinical significance of plasma D-dimer in ovarian cancer: A meta-analysis.Platelets and cancer: a casual or causal relationship: revisited.2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.Cancer-associated thrombosis: an overviewRisk of site-specific cancer in incident venous thromboembolism: a population-based studyPlatelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.Survival analysis in hematologic malignancies: recommendations for cliniciansThe polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.Weight Change and Risk of Venous Thromboembolism: The Tromsø StudyRisk of Ischemic Stroke in Patients With Gastric Cancer: A Nationwide Population-Based Cohort Study.Complications Associated With Use of Long-Term Central Venous Catheters Among Commercially Insured Women With Breast Cancer.Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis.Procoagulant role of neutrophil extracellular traps in patients with gastric cancer.Melanoma growth effects on molecular clearance from tumors and biodistribution into systemic tissues versus draining lymph nodes.Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study.Venous thrombosis and cancer: from mouse models to clinical trials.Incidence and Risk Factors of Thromboembolism with Multiple Myeloma in the Presence of Death as a Competing Risk: An Empirical Comparison of Statistical MethodologiesJoint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism.Pulmonary embolism in non-brain tumor patients after surgery-a retrospective study in China.Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical TreatmentRisk marker associations with venous thrombotic events: a cross-sectional analysis.Asparaginase in the treatment of non-ALL hematologic malignancies.The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).
P2860
Q26740812-EF303CFD-2F6C-4346-911B-8C0F7C4388AFQ27342329-46963808-D974-4BB9-85F5-B08B7C062F2CQ28079318-EE2F6F72-D2E6-4F4A-8703-8323E16411D2Q30251535-95C4F39C-37A3-4FDA-AF7F-F4B55B321B8FQ30381707-3A5CA325-C8FF-4270-B4CB-483A73CE2FE1Q30995983-A98F079A-BE6E-4C81-BCB6-C1BFF4DBA171Q33413690-69709F88-6D7D-40FA-969C-5B1BE9496D5CQ33416926-F81AA38B-DB4D-449C-8DC1-3164E3468ACCQ33418295-54CFCD37-1F94-459E-84C7-081C399F0412Q33419213-88D896F0-8844-4953-91A4-1B201407B602Q33427150-F152E3B6-A03A-4E48-9E31-5D9AA0D73E80Q33616584-3065EC22-71CE-4EE4-A230-8068B71D9F7BQ33691499-039D22A3-50DC-408C-B47A-65B75F7E0C35Q33734478-BFEBC527-789D-41C4-9834-7CBFB5B9053AQ33833598-B6EEBE1F-A761-4A63-953D-7F9A7B1DC827Q34294719-47EF732A-65B9-4F5D-89AC-CB997D72BD75Q34436061-D97B21AF-A69A-40FC-AFE7-803E60F002B5Q34655217-D76EB9E3-0D91-45E4-AAE4-D7501F89BFE4Q35118211-4366B957-7858-4321-8BDB-98E1EFB6C932Q35124116-6F84634F-DF15-4C21-ABDD-80723818B426Q35988386-A8EB65FF-417D-471A-8482-E28A4BA98114Q36036279-F74B4642-6898-40E4-95C5-574571C5FDC0Q36051099-58BF34DA-7CDF-46EC-8291-4C22872CE9D2Q36229612-CC564FDA-177D-4873-BB2C-40AE1E6E95FBQ36256062-0F14A05C-E28C-47CD-925F-BC8CF1E6F2E8Q36285407-D1DE9D4B-D6E3-4199-8890-149606E07F6CQ36372550-4F907588-343C-4050-A1A9-FDFB6D776FE3Q36372812-7B3A2B0D-00E1-4C5E-AB41-C89CC419EAC4Q36464340-E0C4D604-3119-432E-8C49-421B3E1F572AQ36494851-A659ED73-73F4-49C1-BFFF-50C2E3E2662CQ36625144-B7493394-F86A-4097-9E5D-8F0EE85C6576Q36636558-432ABFAD-FC7B-4D45-9540-F4C93FB2A94CQ37069353-083FEA94-AA70-4222-BB02-E352C6472167Q37331210-330CF966-A0F5-482B-835A-953BB818548EQ37587189-861DDD52-16FD-4112-8E5C-00806B1DF6C4Q37609437-6A276256-9CD1-4F93-8197-0326EC372C5BQ37624146-A1B3CBB5-E190-450C-A5C8-E51ACE5B1E9FQ37657294-EE51208F-DBE5-4A2D-9EB1-BAC484B21A18Q38187018-04151A66-A8B1-41F7-93ED-6D7CD2674024Q38261764-17134007-F375-4D86-9583-DB39ED93D8C7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epidemiology of cancer-associated venous thrombosis.
@en
type
label
Epidemiology of cancer-associated venous thrombosis.
@en
prefLabel
Epidemiology of cancer-associated venous thrombosis.
@en
P2093
P1433
P1476
Epidemiology of cancer-associated venous thrombosis.
@en
P2093
Henri H Versteeg
Jasmijn F Timp
Sigrid K Braekkan
Suzanne C Cannegieter
P304
P356
10.1182/BLOOD-2013-04-460121
P407
P577
2013-08-01T00:00:00Z